However, HOMA-IR is the only independent predictor of a reduction in γGT; thus, other differences in liver metabolism could mediate the relationship between improvements in NAFLD and insulin sensitivity after the VLCKD [30]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.